Data further examines Seroquel. (quetiapine fumarate) treatment for bipolar depression

home   >   blogdigger

AstraZeneca (NYSE: AZN) today announced additional findings at the annual meeting of the American Psychiatric Association (APA) from the BOLDER (BipOLar DEpRession) trial, a large-scale study that examined SEROQUEL as a treatment for depressive episodes in patients with bipolar I and II disorders. Results from this trial showed SEROQUEL (600 mg/day and 300 mg/day) significantly improved quality of life measures on the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q SF).

- link to Data further examines Seroquel. (quetiapine fumarate) treatment for bipolar depression -
Last update: 05/26/2005

Recommended Reading

    Quetiapine promising for developmental disorders. (Children and Teens). : An article from: Clinical Psychiatry News
    Seroquel shortage indicative of supply problems. (Sharp Increase in Drug Shortages). : An article from: Internal Medicine News
    Primer for Prescription Medications: the antipsychotic medicines--atypical. : An article from: Annals of the American Psychotherapy Association
    Developmental disorders respond to Quetiapine: moderate to high dose.(Behavioral Pediatrics) : An article from: Pediatric News
    Developmental disorders respond to Quetiapine: moderate to high dose.(Behavioral Pediatrics) : An article from: Pediatric News
    Antipsychotic-induced metabolic syndrome costly: clinical, economic impact.(Rx)(Clozaril, Zyprexa, Seroquel, and other antipsychotics may cause diabet ... rome) : An article from: Family Practice News
    Antipsychotic-induced metabolic syndrome costly: clinical, economic impact.(Rx)(Clozaril, Zyprexa, Seroquel, and other antipsychotics may cause diabet ... rome) : An article from: Family Practice News
    Primer for Prescription Medications: the antipsychotic medicines--atypical. : An article from: Annals of the American Psychotherapy Association